Signal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2007-05-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2007-11202PMID 17522439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease

  2007cited by this paper
• Gene expression correlates of neurofibrillary tangles in Alzheimer's disease.

  2006cited by this paper
• Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease

  2006cited by this paper
• Apoptosis in Alzheimer disease: a mathematical improbability.

  2006cited by this paper
• Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains.

  2006cited by this paper
• The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease.

  2006cited by this paper
• Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease

  2006cited by this paper
• Tau phosphorylation in Alzheimer's disease: pathogen or protector?

  2005cited by this paper
• β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways

  2005cited by this paper
• Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.

  2004cited by this paper
• Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease

  2004cited by this paper
• BACE1 Suppression by RNA Interference in Primary Cortical Neurons*

  2004cited by this paper
• Neuroprotective properties of Bcl‐w in Alzheimer disease

  2004cited by this paper
• Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid‐β as Protective Adaptations to Alzheimer Disease

  2004cited by this paper
• Alzheimer's disease: the two-hit hypothesis

  2004cited by this paper
• Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease.

  2004cited by this paper
• Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways

  2003cited by this paper
• Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease

  2003cited by this paper
• Proteomic identification of nitrated proteins in Alzheimer's disease brain

  2003cited by this paper
• A Metabolic Basis for Alzheimer Disease

  2003cited by this paper
• Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection*

  2002cited by this paper
• Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease.

  2002cited by this paper
• Oxidative stress increases expression and activity of BACE in NT2 neurons.

  2002cited by this paper
• Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.

  2002cited by this paper
• beta-Amyloid induces oxidative DNA damage and cell death through activation of c-Jun N terminal kinase.

  2002cited by this paper
• Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

  2002cited by this paper
• Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

  2002cited by this paper
• The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.

  2002cited by this paper
• High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal*

  2002cited by this paper
• The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease

  2002cited by this paper
• β‐Amyloid Induces Oxidative DNA Damage and Cell Death through Activation of c‐Jun N Terminal Kinase

  2002cited by this paper
• Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain

  2002cited by this paper
• Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response.

  2002cited by this paper
• Abeta[25-35] peptide and iron promote apoptosis in lymphocytes by an oxidative stress mechanism: involvement of H2O2, caspase-3, NF-kappaB, p53 and c-Jun.

  2002cited by this paper
• Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71

  2002cited by this paper
• Aβ[25–35] Peptide and Iron Promote Apoptosis in Lymphocytes by an Oxidative Stress Mechanism: Involvement of H2O2, Caspase-3, NF-κB, p53 and c-Jun

  2002cited by this paper
• Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

  2002cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.

  2001cited by this paper
• Abortive apoptosis in Alzheimer's disease

  2001cited by this paper
• Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration

  2001cited by this paper
• Do neurons have a choice in death?

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001influential reference
• Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

  2001cited by this paper
• β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand

  2001cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• β‐Amyloid‐induced neuronal apoptosis requires c‐Jun N‐terminal kinase activation

  2001cited by this paper
• Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies

  2001cited by this paper
• Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD

  2001cited by this paper
• Activation of the JNK/p38 Pathway Occurs in Diseases Characterized by Tau Protein Pathology and Is Related to Tau Phosphorylation But Not to Apoptosis

  2001cited by this paper
• CEP‐1347/KT‐7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ‐induced cortical neuron apoptosis

  2001cited by this paper
• Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

  2001cited by this paper
• Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

  2001cited by this paper
• Redox-active iron mediates amyloid-beta toxicity.

  2001cited by this paper
• Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

  2001cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine

  2001cited by this paper
• JNK activation is associated with intracellular beta-amyloid accumulation.

  2000cited by this paper
• Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells.

  2000cited by this paper
• A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

  2000cited by this paper
• Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal

  2000cited by this paper
• In Alzheimer's Disease, Heme Oxygenase Is Coincident with Alz50, an Epitope of τ Induced by 4‐Hydroxy‐2‐Nonenal Modification

  2000cited by this paper
• JNK and p38 stresskinases--degenerative effectors of signal-transduction-cascades in the nervous system.

  2000cited by this paper
• Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.

  2000cited by this paper
• JNK activation is associated with intracellular β-amyloid accumulation

  2000cited by this paper
• Oxidative Stress Induces Increase in Intracellular Amyloid β-Protein Production and Selective Activation of βI and βII PKCs in NT2 Cells

  2000cited by this paper
• Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome

  2000influential reference
• Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.

  2000cited by this paper
• Overexpression of Heme Oxygenase in Neuronal Cells, the Possible Interaction with Tau*

  2000cited by this paper
• Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease

  2000cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999influential reference
• Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology

  1999cited by this paper
• Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

  1999cited by this paper
• Neurons may live for decades with neurofibrillary tangles.

  1999cited by this paper
• p38 Kinase Is Activated in the Alzheimer's Disease Brain

  1999cited by this paper
• Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.

  1999cited by this paper
• Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

  1999cited by this paper
• Early glycoxidation damage in brains from Down's syndrome.

  1998cited by this paper
• The expression of key oxidative stress-handling genes in different brain regions in alzheimer’s disease

  1998cited by this paper
• Abnormalities of mitochondrial enzymes in Alzheimer disease

  1998cited by this paper
• Is oxidative damage central to the pathogenesis of Alzheimer disease?

  1998cited by this paper
• Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

  1998cited by this paper
• Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

  1998cited by this paper
• Apoptosis and Alzheimer's Disease

  1998cited by this paper
• Abnormal localization of iron regulatory protein in Alzheimer's disease.

  1998cited by this paper
• A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide

  1997cited by this paper
• 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes.

  1997cited by this paper
• Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain.

  1997cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997cited by this paper
• Oxidants as stimulators of signal transduction.

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation

  1997cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• Serotonin Metabolism and Release in Frontal Cortex of Rats on a Vitamin E‐Deficient Diet

  1996cited by this paper
• Evidence of neuronal oxidative damage in Alzheimer's disease.

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Oxidative damage in Alzheimer's

  1996cited by this paper
• Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

  1996cited by this paper
• Radical AGEing in Alzheimer's disease.

  1995cited by this paper
• Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress

  1995cited by this paper
• Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease

  1995cited by this paper

• Integrated analysis strategies reveal the pharmacodynamic substances and action mechanisms of Huangqi San in the treatment of Alzheimer's disease.

  2025cites this paper
• Torreya grandis oil attenuates cognitive impairment in scopolamine-induced mice.

  2023cites this paper
• Many Paths to Alzheimer’s Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors

  2023cites this paper
• Model scenarios for cell cycle re-entry in Alzheimer's disease

  2022cites this paper
• Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope

  2022cites this paper
• Neuroprotective effects of hawthorn leaf flavonoids in Aβ25–35‐induced Alzheimer's disease model

  2022cites this paper
• Anti-tuberculotic thionamide antibiotics show antioxidative and neuronal cytoprotective nature by inhibiting amyloid formation in human insulin and amyloid β-42

  2021cites this paper
• Bridging the Gap Between Nature and Antioxidant Setbacks: Delivering Gallic Acid to Mitochondria.

  2021cites this paper
• Molecular targets of dietary phytochemicals for human chronic diseases: Cancer, obesity, and alzheimer's diseases

  2020cites this paper
• Fundamental Approaches to Screen Abnormalities in Drosophila

  2020influential citation
• Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity

  2020cites this paper
• Investigating blood plasma levels of cytokines and amyloid-β as potential diagnostic biomarkers for preclinical Alzheimer’s disease

  2019cites this paper
• Early-Onset Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer’s Disease

  2019cites this paper
• Edible mushrooms as mediators of sustainability and human health

  2019cites this paper
• Reactive Oxygen Species Detection of Drosophila Cells by Flow Cytometry

  2019cites this paper
• Metallomics for Alzheimer's disease treatment: Use of new generation of chelators combining metal-cation binding and transport properties.

  2018cites this paper
• Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.

  2018cites this paper
• Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology

  2018cites this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cites this paper
• Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity

  2018cites this paper
• Chlorogenic Acid and Mental Diseases: From Chemistry to Medicine

  2017cites this paper
• Palmitic Acid Curcumin Ester Facilitates Protection of Neuroblastoma against Oligomeric Aβ40 Insult

  2017cites this paper
• Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.

  2017cites this paper
• The Relationship Between Caring For Individuals Diagnosed With Prader-Willi Syndrome And Caregiver Stress

  2017influential citation
• Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer’s and neurodegenerative diseases

  2017cites this paper
• Cyclin dependent kinase 5: A novel avenue for Alzheimer's disease.

  2017cites this paper
• Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells

  2017cites this paper
• Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease

  2016influential citation
• Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease.

  2016cites this paper
• The Role of Berberine in the Multi-Target Treatment of Senile Dementia.

  2015cites this paper
• Potential Natural Products for Alzheimer’s Disease: Targeted Search Using the Internal Ribosome Entry Site of Tau and Amyloid-β Precursor Protein

  2015cites this paper
• Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.

  2015cites this paper
• Circulating Oxidative Damage and Antioxidant Defense System Biomarkers in Early Stage Alzheimer’s Disease

  2015cites this paper
• Bridging the gap between nature and antioxidant setbacks: delivering caffeic acid to mitochondria.

  2015cites this paper
• Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer's disease.

  2015cites this paper
• Flavonoids as regulators of amyloid precursor protein processing

  2014cites this paper
• Mitochondrial Biology in Sporadic Inclusion Body Myositis

  2014cites this paper
• Alzheimer’s Disease Pathology and Oxidative Stress: Possible Therapeutic Options

  2014cites this paper
• Alzheimer’s Disease Pathology and Oxidative Stress: Possible Therapeutic

  2014cites this paper
• Loss of the m‐AAA protease subunit AFG3L2 causes mitochondrial transport defects and tau hyperphosphorylation

  2014cites this paper
• NOVEL COMPOUNDS AS POTENTIAL ALZHEIMER'S DISEASE THERAPEUTICS AND INHIBITORS OF THE NLRP3 INFLAMMASOME

  2014cites this paper
• Oxidative stress in Alzheimer’s disease

  2014cites this paper
• Alzheimer's disease and antioxidant therapy: how long how far?

  2013cites this paper
• Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

  2013cites this paper
• New Lipoxygenase Inhibitors of Reactive Oxygen Species Production in Cellular Models of Amyloid (A2) Toxicities

  2013cites this paper
• Phenolic content, antioxidant and antibacterial activity of selected natural sweeteners available on the Polish market

  2013cites this paper
• Antioxidant activity of galantamine and some of its derivatives.

  2013cites this paper
• The Effect of Seeds and Fruit Pulp of Adansonia digitata L. (Baobab) on Ehrlich Ascites Carcinoma

  2013cites this paper
• Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza bunge, as a multifunctional agent for the treatment of Alzheimer’s disease

  2013cites this paper
• Distinctive roles of PLD signaling elicited by oxidative stress in synaptic endings from adult and aged rats.

  2012cites this paper
• Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!

  2012cites this paper
• Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

  2012cites this paper
• Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.

  2012cites this paper
• Altered Mitochondrial Retrograde Signaling in Response to mtDNA Depletion or a Ketogenic Diet

  2012cites this paper
• Neurodegenerative processes in Alzheimer's disease: an overview of pathogenesis with strategic biomarker potential

  2011cites this paper
• Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.

  2011cites this paper
• Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention

  2011influential citation
• Glutathione‐S‐transferase P1 is a critical regulator of Cdk5 kinase activity

  2011cites this paper
• Early-onset dysfunction of retrosplenial cortex precedes overt amyloid plaque formation in Tg2576 mice.

  2011cites this paper
• Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What

  2011cites this paper
• Frontiers in Alzheimer’s disease therapeutics

  2011cites this paper
• Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease

  2011cites this paper
• “CLICKED” BIVALENT MULTIFUNCTIONAL LIGANDS IN ALZHEIMER’S DISEASE.

  2011cites this paper
• Análise comparativa do perfil lipídico do plasma seminal associado ao estresse oxidativo

  2011cites this paper
• The selective and competitive N-methyl-D-aspartate receptor antagonist, (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid, prevents synaptic toxicity induced by amyloid-β in mice.

  2011cites this paper
• Animal Models of Alzheimer's Disease

  2011cites this paper
• Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates

  2010cites this paper
• Bivalent Ligands Containing Curcumin and Cholesterol As Multifunctional A β Oligomerization Inhibitors : Design , Synthesis , and Biological Characterization

  2010cites this paper
• Leaf and stem of Vitis amurensis and its active components protect against amyloid β protein (25–35)-induced neurotoxicity

  2010cites this paper
• Neurochemical Aspects of Neurodegenerative Diseases

  2010cites this paper
• Novel therapeutics for Alzheimer's disease: an update.

  2010cites this paper
• Ablation of the Locus Coeruleus Increases Oxidative Stress in Tg-2576 Transgenic but Not Wild-Type Mice

  2010cites this paper
• Naturally occurring phytochemicals for the prevention of Alzheimer’s disease

  2010cites this paper
• Iron and Mechanisms of Neurotoxicity

  2010cites this paper
• "Clicked" bivalent ligands containing curcumin and cholesterol as multifunctional abeta oligomerization inhibitors: design, synthesis, and biological characterization.

  2010cites this paper
• TRPM2 channel properties, functions and therapeutic potentials

  2010cites this paper
• Oxidative stress in Alzheimer disease: a possibility for prevention.

  2010influential citation
• Mitochondrial Dynamics in Alzheimer’s Disease

  2010influential citation
• Direct and Indirect Roles of Cyclin-dependent Kinase 5 as an Upstream Regulator in the c-Jun NH 2-Terminal Kinase Cascade : Relevance to Neurotoxic Insults in Alzheimer ’ s Disease

  2009cites this paper
• Factores implicados en la patogénesis de la enfermedad de alzheimer. Estrés oxidativo

  2009cites this paper
• Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.

  2009cites this paper
• Mitochondrial Drugs for Alzheimer Disease

  2009cites this paper
• Oxidative stress up‐regulates presenilin 1 in lipid rafts in neuronal cells

  2009cites this paper
• Extracts of Cynomorium songaricum protect SK‐N‐SH human neuroblastoma cells against staurosporine‐induced apoptosis potentially through their radical scavenging activity

  2009cites this paper
• Amyloid-β and aluminum ions enhance neuronal damage mediated by NMDA-activated glutamate receptors

  2009cites this paper
• Recent advances in our understanding of neurodegeneration

  2009cites this paper
• Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases

  2009cites this paper
• Alzheimer's disease: from pathology to therapeutic approaches.

  2009cites this paper
• Synaptic transmission block by presynaptic injection of oligomeric amyloid beta

  2009cites this paper
• Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen

  2009cites this paper
• Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry

  2009cites this paper
• Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals.

  2009cites this paper
• Argyrophilic grain disease.

  2008cites this paper
• Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?

  2008cites this paper
• Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.

  2008cites this paper
• Association of Selenoprotein P with Alzheimer's Pathology in Human Cortex

  2008cites this paper
• Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease

  2008cites this paper
• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

  2008cites this paper
• Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

  2008cites this paper
• From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease.

  2008cites this paper